98751-79-2

Basic information

• Product Name: paeonilactone A
• Synonyms: paeonilactone A;(-)-Paeonilactone;[3R,3aα,7aα,(-)]-3a,6,7,7a-Tetrahydro-6β-hydroxy-3α,6-dimethylbenzofuran-2,5(3H,4H)-dione;(3R,3aR,6S,7aR)-Tetrahydro-6-hydroxy-3,6-dimethyl-2,5(3H,4H)-benzofurandione
• CAS NO: 98751-79-2
• Molecular Formula: C10H14O4
• Molecular Weight: 198.21576
• Mol File: 98751-79-2.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: paeonilactone A(CAS DataBase Reference)
• NIST Chemistry Reference: paeonilactone A(98751-79-2)
• EPA Substance Registry System: paeonilactone A(98751-79-2)

Safety Data

• Hazardous Substances Data: 98751-79-2(Hazardous Substances Data)

Usage

Description

Paeonilactone A is a natural chemical compound derived from the roots of Paeonia lactiflora, commonly known as the peony plant. It is a member of the lactone class of organic compounds, which are cyclic esters formed from hydroxy acids. Paeonilactone A has exhibited a range of biological activities, such as anti-inflammatory and neuroprotective properties, making it a promising candidate for the treatment of neurodegenerative diseases and inflammatory conditions. Its antioxidant effects also contribute to its potential health benefits.

Uses

Used in Pharmaceutical Industry:
Paeonilactone A is used as a potential therapeutic agent for neurodegenerative diseases due to its neuroprotective properties. It may help in the treatment and management of conditions such as Alzheimer's disease, Parkinson's disease, and other related disorders by protecting neurons from damage and degeneration.
Used in Anti-inflammatory Applications:
Paeonilactone A is used as an anti-inflammatory agent for the treatment of inflammatory conditions. Its anti-inflammatory properties can help reduce inflammation and alleviate symptoms associated with various inflammatory diseases, such as arthritis, asthma, and inflammatory bowel disease.
Used in Antioxidant Formulations:
Paeonilactone A is used as an antioxidant in health and wellness products. Its antioxidant effects can help neutralize free radicals, protect cells from oxidative damage, and contribute to overall health and well-being.
Used in Drug Development:
Paeonilactone A is used as a lead compound in the development of new drugs for various medical conditions. Its diverse biological activities and potential therapeutic effects make it a valuable candidate for further research and drug development.

Upstream product

• 139685-65-7 (3aS,4aR,7R,7aR,8aR)-2,2,3a,7-Tetramethyl-hexahydro-furo[2',3':4,5]benzo[1,2-d][1,3]dioxol-6-one 
• 139685-64-6 (3aS,4aR,7S,7aR,8aR)-2,2,3a,7-Tetramethyl-hexahydro-furo[2',3':4,5]benzo[1,2-d][1,3]dioxol-6-one 
• 139618-30-7 (3aR,4R,6S,7aR)-6-Isopropenyl-2,2,3a-trimethyl-4-phenylselanyl-hexahydro-benzo[1,3]dioxole 
• 139618-33-0 (3aR,4R,4aS,7aR,8aR)-4-Iodo-2,2,3a-trimethyl-7-methylene-hexahydro-furo[2',3':4,5]benzo[1,2-d][1,3]dioxol-6-one 
• 139618-32-9 2-((3aR,5S,7aS)-2,2,7a-Trimethyl-3a,4,5,7a-tetrahydro-benzo[1,3]dioxol-5-yl)-prop-2-en-1-ol 
• 139685-63-5 (3aS,4aR,7aR,8aR)-2,2,3a-Trimethyl-7-methylene-hexahydro-furo[2',3':4,5]benzo[1,2-d][1,3]dioxol-6-one 
• 139618-31-8 (3aR,5S,7aS)-2,2,7a-Trimethyl-5-(2-methyl-oxiranyl)-3a,4,5,7a-tetrahydro-benzo[1,3]dioxole 
• 24120-79-4 (1R,2R,4S,6S)-(-)-1-methyl-4-(prop-1-en-2-yl)-7-oxabicyclo[4.1.0]heptan-2-ol 
• 124618-13-9 (3aR,4R,4aS,7aR,8aR)-4-Iodo-3a,7-dimethyl-2-trichloromethyl-hexahydro-furo[2',3':4,5]benzo[1,2-d][1,3]dioxol-6-one 
• 124618-09-3 2-((1R,5R)-5-Acetoxy-4-methyl-2-oxo-cyclohex-3-enyl)-propionic acid methyl ester 
• 124618-08-2 2-((1R,5R)-5-Acetoxy-4-methyl-cyclohex-3-enyl)-propionic acid methyl ester 
• 124618-10-6 Acetic acid (3aR,5R,7aS)-3,6-dimethyl-2-oxo-2,3,3a,4,5,7a-hexahydro-benzofuran-5-yl ester 
• 124618-22-0 2-((1R,5R)-5-Acetoxy-4-methyl-cyclohex-3-enyl)-propionic acid 
• 124618-14-0 (3aS,4aR,7aR,8aR)-2,3a,7-Trimethyl-hexahydro-furo[2',3':4,5]benzo[1,2-d][1,3]dioxol-6-one 

Relevant articles and documents

Enantiospecific syntheses of paeonilactone A, paeonilactone B, 7S-paeonimetabolin-I, and 7R-paeonimetabolin-I from R-(-)-carvone

The first enantiospecific syntheses of the title monoterpenes have been accomplished starting with R-(-)-carvone, which made their absolute structures unequivocal.

Efficient synthesis of paeonilactone-A and -B from (-)-carvone

-